HIKMA PHARMACEUTIC.LS-,10
HIKMA PHARMACEUTIC.LS-,10/ GB00B0LCW083 /
H5P
|
6/11/2024 7:31:54 PM
|
Chg.
+0.800
|
Volume |
Bid7:32:10 AM |
Ask7:32:10 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
23.400EUR
|
+3.54%
|
0
Turnover: 0.000 |
23.400Bid Size: 220 |
24.000Ask Size: 220 |
5.17 bill.EUR |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
0.86 USD |
2.50% |
| EPS Diluted: |
- USD |
1.67% |
| Revenues per Share: |
13.00 USD |
20.42% |
| Book Value per Share: |
9.94 USD |
8.53% |
| Cash Flow per Share: |
2.75 USD |
20.94% |
| Dividend per Share: |
0.72 USD |
28.57% |
| Total |
in mill. |
|
| Revenues: |
2,875.00 USD |
14.22% |
| Net Income: |
190.00 USD |
1.06% |
| Operating Cash Flow: |
608.00 USD |
- |
| Cash and Cash Equivalents: |
205.00 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
29.20 |
26.51 |
| P/S Ratio: |
1.93 |
1.75 |
| P/BV ratio: |
2.53 |
2.29 |
| P/CF Ratio: |
9.13 |
8.29 |
| PEG: |
11.66 |
10.59 |
| Earnings Yield: |
3.43% |
3.77% |
| Dividend Yield: |
2.87% |
3.16% |
| Market Capitalization |
|
| Market Capitalization: |
5.17 bill. EUR |
4.57 bill. EUR |
| Free Float Market Cap.: |
- EUR |
- EUR |
| Market Cap. / Employee: |
- EUR |
- EUR |
| Shares Outstanding: |
221.08 mill. |
|
Profitability
| Gross Profit Margin: |
48.35% |
| EBIT Margin: |
12.77% |
| Net Profit Margin: |
6.61% |
| Return on Equity: |
8.64% |
| Return on Assets: |
4.06% |
Financial Strength
| Liquidity I / Cash Ratio: |
15.31% |
| Liquidity II / Quick Ratio: |
76.85% |
| Liquidity III / Current Ratio: |
156.83% |
| Debt / Equity Ratio: |
112.92% |
| Dynam. Debt / Equity Ratio: |
408.22% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
- USD |
| Net Income / Employee: |
- USD |
| Total Assets / Employee: |
- USD |
| * Fiscal Year End: |
12/31/2023 |
| Accounting Standard: |
IFRS |
